Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody

Ye, J; Jia, YJ; Tuhin, IJ; Tan, JW; Monty, MA; Xu, N; Kang, LQ; Li, MH; Lou, XY; Zhou, MX; Fang, XY; Shao, JQ; Zhu, HJ; Yan, ZQ; Yu, L

Yan, ZQ; Yu, L (通讯作者),East China Normal Univ, Inst Biomed Engn & Technol, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200062, Peoples R China.

MOLECULAR THERAPY-ONCOLYTICS, 2022; 24 (): 719

Abstract

Although chimeric antigen receptor (CAR) T cell immunotherapy has shown promising significance in B cell malignancies, success against T cell malignan......

Full Text Link